Nonalcoholic steatosis and steatohepatitis -: III.: Peroxisomal β-oxidation, PPARα, and steatohepatitis

被引:210
作者
Reddy, JK [1 ]
机构
[1] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 2001年 / 281卷 / 06期
关键词
peroxisomes; fatty acid beta- and omega-oxidation; peroxisomal proliferator-activated receptor alpha; peroxisomal biogenesis disorders;
D O I
10.1152/ajpgi.2001.281.6.G1333
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Peroxisomes are involved in the beta -oxidation chain shortening of long-chain and very-long-chain fatty acyl-CoAs, long-chain dicarboxylyl-CoAs, the CoA esters of eicosanoids, 2-methyl-branched fatty acyl-CoAs, and the CoA esters of the bile acid intermediates, and in the process, they generate H2O2. There are two complete sets of beta -oxidation enzymes present in peroxisomes, with each set consisting of three distinct enzymes. The classic PPAR alpha -regulated and inducible set participates in the beta -oxidation of straight-chain fatty acids, whereas the second noninducible set acts on branched-chain fatty acids. Long-chain and very-long-chain fatty acids are also metabolized by the cytochrome P-450 CYP4A omega -oxidation system to dicarboxylic acids that serve as substrates for peroxisomal beta -oxidation. Evidence derived from mouse models of PPAR alpha and peroxisomal beta -oxidation deficiency highlights the critical importance of the defects in PPAR alpha- inducible beta -oxidation in energy metabolism and in the development of steatohepatitis.
引用
收藏
页码:G1333 / G1339
页数:7
相关论文
共 35 条
[1]   Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2 [J].
Abu-Elheiga, L ;
Matzuk, MM ;
Abo-Hashema, KAH ;
Wakil, SJ .
SCIENCE, 2001, 291 (5513) :2613-2616
[2]   Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids [J].
Baes, M ;
Huyghe, S ;
Carmeliet, P ;
Declercq, PE ;
Collen, D ;
Mannaerts, GP ;
Van Veldhoven, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :16329-16336
[3]   Mouse models for peroxisome biogenesis disorders [J].
Baes, M .
CELL BIOCHEMISTRY AND BIOPHYSICS, 2000, 32 (1-3) :229-237
[4]   Regulation of transcription by a protein methyltransferase [J].
Chen, DG ;
Ma, H ;
Hong, H ;
Koh, SS ;
Huang, SM ;
Schurter, BT ;
Aswad, DW ;
Stallcup, MR .
SCIENCE, 1999, 284 (5423) :2174-2177
[5]  
de Montellano P.R. Ortiz., 1995, CYTOCHROME P450 STRU
[6]   Peroxisome proliferator-activated receptors: Nuclear control of metabolism [J].
Desvergne, B ;
Wahli, W .
ENDOCRINE REVIEWS, 1999, 20 (05) :649-688
[7]   Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase -: Implications for peroxisome proliferator-activated receptor α natural ligand metabolism [J].
Fan, CY ;
Pan, J ;
Usuda, N ;
Yeldandi, AV ;
Rao, MS ;
Reddy, JK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15639-15645
[8]   Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta [J].
Forman, BM ;
Chen, J ;
Evans, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) :4312-4317
[9]  
Glass CK, 2000, GENE DEV, V14, P121
[10]   Mechanism of action of the nongenotoxic peroxisome proliferators:: Role of che peroxisome proliferator-activated receptor α [J].
Gonzalez, FJ ;
Peters, JM ;
Cattley, RC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (22) :1702-1709